Vaccine(s) were received on 10/28/2016
Patient sex : U
Reaction was life threatening?: N
Patient eventually recovered from reaction ?: U
Patient eventually died?: N

The following Data for this patients ALLERGIES is available: [ ]

Description of adverse reaction: This spontaneous report as received from medical assistant refers to a patient of unknown demographics. The patient's concurrent conditions, medical history and drug reactions/allergies were not reported. Concomitant therapy included sterile diluent(MERCK STERILE DILUENT). On 28-OCT-2016 the patient was vaccinated with unspecified doses of expired VARIVAX (lot # K018960, expiry date: 15-OCT-2016) and/or M-M-R II injection (lot # K020188, expiry date: 22-OCT-2016) (dose, frequency and route were not reported) for prophylaxis (expired product administered). It was not reported that, sterile diluent(MERCK STERILE DILUENT) used to reconstitute vaccines was expired. The reporter also stated that, it was unknown whether the patient received MMR II or VARIVAX separately or MMR II concomitant with VARIVAX. No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same reporter. Albumin status for M-M-R II is recombinant human albumin (rHA).

Vaccine(s) associated with report# 747590

Type	Name	Manufacturer	Vaccine LOT #	Dose Series	ROUTE	Site
MMR	MEASLES + MUMPS + RUBELLA (MMR II)	MERCK & CO. INC.	K020188	0	UN	UN
VARCEL	VARICELLA (VARIVAX)	MERCK & CO. INC.	K018960	0	UN	UN

Symptoms(s) associated with report# 747590

Expired product administered
No adverse event